76939-72-5

Basic information

• Product Name: ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate
• Synonyms: ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate
• CAS NO: 76939-72-5
• Molecular Formula: C41H53N13O31P4
• Molecular Weight: 1347.823064
• Mol File: 76939-72-5.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 2.28g/cm³
• Refractive Index: 1.869
• CAS DataBase Reference: ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate(CAS DataBase Reference)
• NIST Chemistry Reference: ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate(76939-72-5)
• EPA Substance Registry System: ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate(76939-72-5)

Safety Data

• Hazardous Substances Data: 76939-72-5(Hazardous Substances Data)

Usage

Description

Ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate are a group of essential nucleotides that play significant roles in the formation and function of RNA molecules. Ribosylthymine phosphate, also known as thymidine monophosphate, is a nucleotide consisting of the sugar deoxyribose and the nitrogenous base thymine, and it is a key component of DNA. Pseudouridine phosphate is a modified nucleotide formed by the isomerization of uridine, contributing to RNA stability and splicing. Cytidine phosphate and guanosine phosphate are crucial nucleotides involved in RNA synthesis and participate in various cellular processes, including protein synthesis and gene regulation. Collectively, these four nucleotides enhance the diversity and functionality of RNA molecules within the cell.

Uses

Used in Pharmaceutical Industry:
Ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate are used as therapeutic agents for their potential roles in modulating RNA stability, splicing, and synthesis, which can have implications in the treatment of various diseases, including genetic disorders and cancer.
Used in Biotechnology Industry:
These nucleotides are used as components in the synthesis of RNA molecules for various biotechnological applications, such as the development of RNA-based drugs, vaccines, and gene therapies.
Used in Research and Development:
Ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate are utilized in research settings to study the mechanisms of RNA synthesis, stability, and function, as well as to investigate their roles in cellular processes and disease pathways.
Used in Diagnostics:
These nucleotides can be employed in the development of diagnostic tools and assays to detect and measure their levels in biological samples, which may provide insights into disease progression and response to treatment.
Used in Drug Delivery Systems:
Ribosylthymine phosphate-pseudouridine phosphate-cytidine phosphate-guanosine phosphate can be incorporated into drug delivery systems to improve the targeting, bioavailability, and therapeutic efficacy of RNA-based drugs and therapies.

InChI:InChI=1/C41H53N13O31P4/c1-14-7-53(41(65)49-32(14)60)36-23(57)27(16(9-55)79-36)83-87(69,70)75-10-17-28(22(56)26(78-17)15-8-51(5-2-4-42)39(63)50-33(15)61)84-88(71,72)77-12-19-30(25(59)35(80-19)52-6-3-20(43)46-40(52)64)85-89(73,74)76-11-18-29(82-86(66,67)68)24(58)37(81-18)54-13-45-21-31(54)47-38(44)48-34(21)62/h3,6-8,13,16-19,22-30,35-37,55-59H,2,5,9-12H2,1H3,(H,69,70)(H,71,72)(H,73,74)(H2,43,46,64)(H,49,60,65)(H,50,61,63)(H2,66,67,68)(H3,44,47,48,62)/t16-,17-,18-,19-,22+,23-,24-,25-,26+,27-,28-,29-,30-,35-,36-,37-/m1/s1